C CELL MATTERS UNLEASHING YOUR CELL THERAPY
LIVE

Serial Number

90835684

Owner

CELL MATTERS S.A.

Attorney

Dana Dickson

Filing Date

Jul 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

C CELL MATTERS UNLEASHING YOUR CELL THERAPY Trademark

Serial Number: 90835684 • Registration: 6843055

C CELL MATTERS UNLEASHING YOUR CELL THERAPY is a trademark filed by CELL MATTERS S.A. on July 19, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CELL MATTERS S.A.

Avenue de l'Hôpital, 1
Liège 4000 , BE

Entity Type: 99

Trademark Details

Filing Date

July 19, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Treatment of biomaterials for the manufacture of products for others by means of cryogenic processing; cryogenic preservation of pharmaceutical products; Cryopreservation services; Custom assembly of materials for others; Contract manufacturing of bio-chemical and pharmaceutical products for third parties

Storage services for human cells and tissues and other biological material for medical, therapeutic, biotechnological use

vitrification solutions, namely, cryogenic preparations in liquid state for use in chilling and freezing of cells for medical purposes; Reagents for medical purposes; Preparations for cryopreservation of cells for medical purposes, in particular cryopreservative buffers and molecules for use in chilling and freezing of cells for medical purposes; biological tissue cultures for medical and veterinary use; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for the treatment of wounds; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for the treatment of tumors, namely, for suppressing tumors; Pharmaceutical preparations for the treatment of chemical imbalances; Veterinary pharmaceutical preparations for the prevention of animal skin disorders; culture medium for cultivating bacteriological and human cell cultures; cellular preparations for medical, pharmaceutical or veterinary use and in particular for gene therapy and for cell therapy, namely, stem cells for medical use, living cells for medical and veterinary use, and genetically engineered tissues for transplant purposes

Cryogenic preparations in liquid state for use in chilling and freezing for medical research purposes; preparations for cryopreservation of cells for medical research purposes, in particular cryopreservative buffers and molecules for use in chilling and freezing of cells for medical research purposes; cell culture media for laboratory, scientific, and research use

Stem cell therapy consultancy services

Research and development of new products for others; Product engineering consultancy services; Research and development of pharmaceutical products; scientific and applied research and development, in particular in the biological, technological and biotechnological fields and in particular in the fields of gene and cell therapy; quality control services; culturing of stem cells, differentiated cells, and human tissue cells for others, for use in cell therapy and for scientific and research purposes; Biotechnology and medical cell therapy research consultancy services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 16, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 16, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 16, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2022 CRFA
ASSIGNED TO LIE
May 3, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 1, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 1, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 1, 2022 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 22, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2021 NWOS
NEW APPLICATION ENTERED
Jul 22, 2021 NWAP